Teva Pharmaceutical Indus... (TEVA)
undefined
undefined%
At close: undefined
16.50
0.12%
After-hours Dec 13, 2024, 04:10 PM EST

Company Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally.

The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams.

It also develops, manufactures, and sells active pharmaceutical ingredients.

In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas.

Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease.

The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease.

Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim.

Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia.

The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited logo
Country IL
IPO Date Feb 16, 1982
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 37,000
CEO Richard D. Francis

Contact Details

Address:
124 Dvora Hanevi'a Street
Tel Aviv,
IL
Website https://www.tevapharm.com

Stock Details

Ticker Symbol TEVA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000818686
CUSIP Number 881624209
ISIN Number US8816242098
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
Richard D. Francis President, Chief Executive Officer & Director
David R. Mcavoy J.D. Executive Vice President & Chief Legal Officer
Eliyahu Sharon Kalif Executive Vice President & Chief Financial Officer
Amir Weiss Senior Vice President & Chief Accounting Officer
Kathleen Veit Senior Vice President, Global Compliance & Ethics Officer
Mark Sabag Executive Vice President of International Markets Commercial
Matthew Shields Executive Vice President of Global Operations
Placid Jover Executive Vice President & CHRO
Ran Meir Head of Investor Relations
Richard Gordon Daniell Executive Vice President of European Commercial

Latest SEC Filings

Date Type Title
Dec 04, 2024 4 Filing
Dec 04, 2024 3 Filing
Nov 21, 2024 4 Filing
Nov 12, 2024 8-K Current Report
Nov 12, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report
Sep 04, 2024 4 Filing
Aug 13, 2024 4 Filing
Aug 13, 2024 4 Filing